These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4836275)

  • 1. Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10.
    Iwamoto Y; Yamagami T; Folkers K; Blomqvist CG
    Biochem Biophys Res Commun; 1974 Jun; 58(3):743-8. PubMed ID: 4836275
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the enzymic capacity of the rat kidney and heart due to unilateral nephrectomy and deoxycorticosterone induced hypertension.
    Mangnall D; Bartley W
    Br J Exp Pathol; 1970 Oct; 51(5):464-76. PubMed ID: 4321628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of activity of succinate dehydrogenase-coenzyme Q10 reductase in leucoytes from patiens with essential hypertension.
    Yamagami T; Iwamoto Y; Folkers K
    Int J Vitam Nutr Res; 1974; 44(3):404-14. PubMed ID: 4156526
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of the combined and separate administration of doxorubicin and coenzyme Q10 on mouse cardiac enzymes.
    Choe JY; Combs AB; Saji S; Folkers K
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):595-8. PubMed ID: 451343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.
    Yamagami T; Shibata N; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):721-7. PubMed ID: 785564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ubiquinone content in albino rat kidney mitochondria following unilateral nephrectomy].
    Fedurov VV
    Biull Eksp Biol Med; 1975 Jul; 80(7):41-3. PubMed ID: 179645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of coenzyme Q 10 on experimental hypertensive cardiovascular disease in desoxycorticosterone acetate-saline loaded rats].
    Igarashi T; Tanabe Y; Nakajima Y; Kobayashi M; Tanaka M
    Nihon Yakurigaku Zasshi; 1972 Jul; 68(4):460-72. PubMed ID: 4676301
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of activities of the succinate dehydrogenase-coenzyme Q reductase in leucocytes of patients with controlled hypertension.
    Yamagami T; Shibata N; Folkers K
    J Med; 1978; 9(2):145-55. PubMed ID: 27566
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of coenzyme Q on the histochemical succinic tetrazolium reductase reaction.
    Horwitz CA; Benitez L; Bray M
    J Histochem Cytochem; 1967 Apr; 15(4):216-24. PubMed ID: 6040100
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.
    Yamagami T; Shibata N; Folkers K
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):273-88. PubMed ID: 1153873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of altered antioxidant enzymes activity and glomerulosclerosis by coenzyme Q10 in alloxan-induced diabetic rats.
    Ahmadvand H; Tavafi M; Khosrowbeygi A
    J Diabetes Complications; 2012; 26(6):476-82. PubMed ID: 22795334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium.
    Bertazzoli C; Sala L; Ballerini L; Watanabe T; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):797-800. PubMed ID: 1005920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models for clinical disease. I. Biochemical cardiotoxicity of a coenzyme Q10-inhibitor in rats.
    Combs AB; Kishi T; Porter TH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):333-9. PubMed ID: 1257616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of 7-chloro-8-methyl-flavin in the rat and its specific antiriboflavin action in the kidney.
    Lambooy JP; Smith CD; Kim YS
    J Nutr; 1971 Sep; 101(9):1137-45. PubMed ID: 5096136
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of coenzyme Q10 on experimental hypertension in rats and dogs.
    Igarashi T; Nakajima Y; Tanaka M; Otake S
    J Pharmacol Exp Ther; 1974 Apr; 189(1):149-56. PubMed ID: 4823289
    [No Abstract]   [Full Text] [Related]  

  • 16. Parameters in determining the specific activity of the succinate dehydrogenase-coenzyme Q10 reductase in mitochondria of leucocytes.
    Iwamoto Y; Yamagami T; Folkers K
    J Nutr Sci Vitaminol (Tokyo); 1974; 20(5):343-50. PubMed ID: 4156366
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative hypertensive activities of the acetates of D-aldosterone and deoxycorticosterone.
    Hall CE; Hall O
    Acta Endocrinol (Copenh); 1967 Mar; 54(3):399-410. PubMed ID: 6071361
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for a deficiency of coenzyme Q10 in human heart disease.
    Folkers K; Littarru GP; Ho L; Runge TM; Havanonda S; Cooley D
    Int Z Vitaminforsch; 1970; 40(3):380-90. PubMed ID: 5450999
    [No Abstract]   [Full Text] [Related]  

  • 19. Ubiquinone and phospholipids as limiting factors in the histochemical demonstration of succinic dehydrogenase activity.
    Wolman M; Bubis JJ
    J Histochem Cytochem; 1967 Feb; 15(2):79-82. PubMed ID: 6031043
    [No Abstract]   [Full Text] [Related]  

  • 20. Deficiency of coenzyme Q in gingiva of patients with periodontal disease.
    Nakamura R; Littarru GP; Folkers K; Wilkinson EG
    Int J Vitam Nutr Res; 1973; 43(1):84-92. PubMed ID: 4696825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.